- About ASF
- What is Autism?
- How Common is Autism?
- Early Signs of Autism
- Autism Diagnosis
- Following a Diagnosis
- Treatment Options
- Beware of Non-Evidence-Based Treatments
- Autism and Vaccines
- Autism Science
- Quick Facts About Autism
- What We Fund
- Autism Sisters Project
- Baby Siblings Research Consortium
- Resources for Grantees
- Funding Calendar
- ASF Funded Research
- ASF Supported Findings
- Apply for a Fellowship
- Apply for a Research Accelerator Grant
- Apply for an Undergraduate Summer Research Grant
- Apply for INSAR Annual Meeting Travel Grant
- Get Involved
- Day of Learning
- Research Recap of 2017
- Contact Us
Board of Directors
Gregg E. Ireland serves as Chairman of the Board. Gregg is formerly a Senior Vice President of Capital World Investors, a division of Capital Research and Management Company. CRMC is the investment advisor for the American Funds with $1 trillion under management. Gregg joined Capital in 1972 and spent his entire career with the Capital organization. Gregg holds a bachelor’s degree summa cum laude from Claremont McKenna College and an MBA from Harvard Business School. Gregg serves on several nonprofit boards dealing with autism and special needs. He is a co-founder and board member of Extraordinary Ventures, Inc., a program that provides employment and social opportunities for young adults with autism. He previously served on the boards of the Autism Society of North Carolina, FPG Child Development Institute, and group home organization Residential Services, Inc. Gregg is also a founding member of the U.S. Marines Raider Foundation. Raised in Southern California, Gregg resides with his wife Lori and their youngest son Vincent in Chapel Hill, North Carolina. The couple has three other adult children as well.
Alison Singer As the mother of a child with autism and legal guardian of her adult brother with autism, Alison is a natural advocate. Since 2007, Singer has served on the national Interagency Autism Coordinating Committee (IACC) which is charged with writing a strategic plan to guide federal spending for autism research. Within the IACC, she serves as co-chair of the safety subcommittee and on the subcommittees for Strategic Plan Review and Services. Singer also currently serves on the executive board of the Yale Child Study Center, on the external advisory board of the Marcus Autism Center at Emory University, and on the external advisory board of the CDC’s Center for Birth Defects and Developmental Disabilities. Alison chairs the International Society for Autism Research public relations committee and is a member of the IMFAR program committee and community advisory committee. She graduated magna cum laude from Yale University with a B.A. in Economics and has an MBA from Harvard Business School.
Thomas R. lnsel, M.D., is a neuroscientist and psychiatrist, is the President and co-Founder of Mindstrong Health. Previous to starting Mindstrong, he was Director of the National Institute of Mental Health (NIMH), the component of the U.S. National Institutes of Health (NIH) committed to research on mental disorders. Dr. Insel served as Director of this $1.5B agency from 2002 until 2015. After ending his 13-year tenure at the NIMH, Dr. Insel moved on to start the first mental health program within Google X Life Sciences (now Verily Life Sciences), which seeks to develop technologies for early detection and treatment of health problems. Formerly, Dr. Insel was Professor of Psychiatry at Emory University, where he was the founding Director of the Center for Behavioral Neuroscience. Dr. Insel has served on the Autism Science Foundation’s scientific advisory board since February 2016.
Michael Lewis is an attorney, mediator, and experienced activist, serving on several non-profit boards in the fields of justice, education, and health. He currently serves as an Alternative Dispute Resolution Consultant at JAMS, where he has successfully mediated dozens of high profile disputes. He is an adjunct professor at Georgetown Law School and also teaches at Harvard Law School. Michael has a BA from Dartmouth and a JD from Georgetown Law School. His granddaughter is diagnosed with autism.
Paul A. Offit, MD is the Chief of the Division of Infectious Diseases at the Children’s Hospital of Philadelphia and a Professor of Pediatrics at the University of Pennsylvania School of Medicine. He is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics bestowed by the University of Maryland Medical School and a Research Career Development Award from the National Institutes of Health. Dr. Offit has published more than 130 papers in medical and scientific journals. He is also the author of the critically acclaimed book “Autism’s False Prophets: Bad Science, Risky Medicine, and the Search for a Cure” (2008), and “Deadly Choices: How the Anti-Vaccine Movement Threatens Us All” (2010). Dr. Offit is also a member of the Institute of Medicine.
Zena Tamler is a partner at Sullivan & Cromwell LLP in the Estates and Personal Group. She represents high net worth individuals and families in connection with their personal legal matters, and also represents fiduciaries and charitable organizations. Ms. Tamler is a member of the New York Board of the Anti-Defamation League, prior co-chair of its Lawyer’s Division, and co-chair of its Professional Advisory Committee on Planned Charitable Giving. She is a Vice-Chair of the Trusts and Estates Group of the UJA-Federation of New York and is a former member of the Board of Creative Alternatives of New York. Ms. Tamler graduated summa cum laude from the University of Pennsylvania with a BA in Economics and History and has a JD from Harvard Law School.